Physical methods to promote drug delivery on mucosal tissues of the oral cavity

Expert Opinion on Drug Delivery

Volumn 10, Issue 10, 2013, Pages 1449-1462

  Giannola, Libero Italo ^a   Sutera, Flavia Maria ^a   De Caro, Viviana ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Electroporation; Eutectic systems; Iontophoresis; Jet injection; Photodynamic therapy; Photomechanical waves; Sonophoresis; Supersaturated systems

Indexed keywords

AMINOLEVULINIC ACID; ATENOLOL; CURCUMIN; DILTIAZEM; ESTRADIOL; GALANTAMINE; HYDROCORTISONE ACETATE; LIDOCAINE; METHYLENE BLUE; NALTREXONE; NICOTINE; ONDANSETRON; PRILOCAINE; ROPINIROLE; SALCATONIN;

DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ELECTROPORATION; EUTECTIC SYSTEM; HUMAN; IONTOPHORESIS; JET INJECTION; JET INJECTOR; LASER; MOUTH CAVITY; MOUTH MUCOSA; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOMECHANICAL WAVE; PROCEDURES; REVIEW; SONOPHORESIS; SUPERSATURATED SYSTEM;

ABSORPTION; ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; HALF-LIFE; HUMANS; IONTOPHORESIS; MOUTH MUCOSA; PERMEABILITY; PHARMACEUTICAL PREPARATIONS;

EID: 84884537934     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.809061     Document Type: Review

References (111)

1. Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J Control Release 2011;153:106-16
2. Hearnden V, Sankar V, Hull K, et al. New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Adv Drug Deliv Rev 2012;64:16-28
3. Campisi G, Paderni C, Saccone R, et al. Human buccal mucosa as an innovative site of drug delivery. Curr Pharm Des 2010;16:641-52
4. Paderni C, Compilato D, Giannola LI, et al. Oral local drug delivery and new perspectives in oral drug formulation. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114:e25-34
5. Giannola LI, De Caro V, Giandalia G, et al. 5-Fluorouracil buccal tablets for locoregional chemotherapy of oral squamous cell carcinoma: Formulation, drug release and histological effects on reconstituted human oral epithelium and porcine buccal mucosa. Curr Drug Deliv 2010;7:109-17
6. Campisi G, Giannola LI, Fucarino A, et al. Medium-term culture of primary oral squamous cell carcinoma in a three-dimensional model: Effects on cell survival following topical 5-Fluororacile delivery by drug-loaded matrix tablets. Curr Pharm Des 2012;18:5411-20
7. Sankar V, Hearnden V, Hull K, et al. Local drug delivery for oral mucosal diseases: Challenges and opportunities. Oral Dis 2011;17:73-84
8. Giannola LI, De Caro V, Giandalia G, et al. Current status in buccal drug delivery. Pharm Tech Eur 2008;20:32-9
9. Cone RA. Barrier properties of mucus. Adv Drug Deliv Rev 2009;61:75-85
10. Sohi H, Ahuja A, Ahmad FJ, et al. Critical evaluation of permeation enhancers for oral mucosal drug delivery. Drug Dev Ind Pharm 2010;36:254-82
11. Wang YY, Lai SK, So C, et al. Mucoadhesive nanoparticles may disrupt the protective human mucus barrier by altering its microstructure. PLoS One 2011;6:e21547
12. ̧ Senel S, Rathbone MJ, Cansiz M, et al. Recent developments in buccal and sublingual delivery systems. Expert Opin Drug Deliv 2012;9:615-28 Pharm Res 2003;20:1125-32
13. Moser K, Kriwet K, Naik A, et al. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 2001;52:103-12
14. Watkinson AC, Joubin H, Green DM, et al. The influence of vehicle permeation from saturated solutions. Int J Pharm 1995;121:27-37
15. Bouropoulos NC, Koutsoukos PG. Spontaneous precipitation of struvite from aqueous solutions. J Crystal Growth 2000;213:381-8
16. Mersmann A. Crystallization and precipitation. Chem Eng Proc 1999;38:345-53
17. Cagno M, Luppi B. Drug supersaturation states induced by polymeric micelles and liposomes: A mechanistic investigation into permeability enhancements. Eur J Pharm Sci 2013;48:775-80
18. Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: The answer to solubility-limited oral bioavailability? J Pharm Sci 2009;98:2549-72
19. Moser K, Kriwet K, Kalia YN, et al. Stabilization of supersaturated solutions of a lipophilic drug for dermal delivery. Int J Pharm 2001;224:169-76
20. Bevernage J, Forier T, Brouwers J, et al. Excipient-mediated supersaturation stabilization in human intestinal fluids. Mol Pharm 2011;8:564-70
21. Ngawhirunpat T, Opanasopit P, Panomsuk S, et al. Skin permeation enhancement of ketoprofen supersaturated solutions with antinucleant polymers. Thai J Pharm Sci 2005;29:11-19
22. Raghavan SL, Trividic A, Davis AF, et al. Crystallization of hydrocortisone acetate: Influence of polymers. Int J Pharm 2001;212:213-21
23. Raghavan SL, Kiepfer B, Davis AF, et al. Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers. Int J Pharm 2001;221:95-105
24. Raghavan SL, Schuessel K, Davis AF, et al. Formation and stabilization of triclosan colloidal suspensions using supersaturated systems. Int J Pharm 2003;261:153-8
25. Fiala S, Jones SA, Brown MB. A fundamental investigation into the effects of eutectic formation on transmembrane transport. Int J Pharm 2010;393:68-73
26. Donaldson D, Meechan JG. A comparison of the effects of EMLA cream and topical 5% lidocaine on discomfort during gingival probing. Anesth Prog 1995;42:7-10
27. Pere P, Iizuka T, Rosenberg PH, et al. Topical application of 5% eutectic mixture of lignocaine and prilocaine (EMLA) before removal of arch bars. Br J Oral Maxillofac Surg 1992;33:153-6
28. Vickers ER, Marzbani N, Gerzina TM, et al. Pharmacokinetics of EMLA cream 50 application to oral mucosa. Anesth Prog 1997;44:32-7
29. Fiala S, Brown MB, Jones SA. Dynamic in-situ eutectic formation for topical drug delivery. J Pharm Pharmacol 2011;63:1428-36
30. Singh I, Sri P. Percutaneous penetration enhancement in transdermal drug delivery. Asian J Pharm 2010;4:92-101
31. Dhamecha DL, Rathi AA, Saifee M, et al. Drug vehicle based approaches of penetration enhancement. Int J Pharm Pharm Sci 2009;1:24-46
32. Van Der Bijl P, Van Eyk AD, Kriel J. Enhancing effect of temperature on the transmucosal penetration kinetics of 17 beta-estradiol. SADJ 2003;58:95-10
33. Kulkarni UD, Mahalingam R, Li X, et al. Effect of experimental temperature on the permeation of model diffusants across porcine buccal mucosa. AAPS PharmSciTech 2011;12:579-86
34. Tomita M, Menconi MJ, Delude RL, et al. Polarized transport of hydrophilic compounds across rat colonic mucosa from serosa to mucosa is temperature dependent. Gastroenterology 2000;118:535-43
35. Khan A, Yasir M, Asif M, et al. Iontophoretic drug delivery: History and applications. J Appl Pharm Sci 2011;1:11-24
36. Giannola LI, De Caro V, Giandalia G, et al. Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features. Eur J Pharm Biopharm 2007;65:238-46
37. Patane MA, Cohen AE, Sheppard JD, et al. Ocular iontophoresis for drug delivery. Retina Today 2011;6:64-6
38. Jacobsen J. Buccal iontophoretic delivery of atenolol HCl employing a new in vitro three-chamber permeation cell. J Control Release 2001;70:83-95
39. Giannola LI, De Caro V, Giandalia G, et al. Release of naltrexone on buccal mucosa: Permeation studies, histological aspects and matrix system design. Eur J Pharm Biopharm 2007;67:425-33
40. Campisi G, Giannola LI, Florena AM, et al. Bioavailability in vivo of naltrexone following transbuccal administration by an electronically-controlled intraoral device: A trial on pigs. J Control Release 2010;145:214-20
41. Oh DH, Chun KH, Jeon SO, et al. Enhanced transbuccal salmon calcitonin (sCT) delivery: Effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation. Eur J Pharm Biopharm 2011;79:357-63
42. Hu L, Damaj BB, Martin R, et al. Enhanced in vitro transbuccal drug delivery of ondansetron HCl. Int J Pharm 2011;404:66-74
43. De Caro V, Giandalia G, Siragusa MG, et al. Galantamine delivery on buccal mucosa: Permeation enhancement and design of matrix tablets. J Bioeqiv Bioavailab 2009;1:127-34
44. Giannola LI, Paderni C, De Caro V, et al. New perspectives in the delivery of galantamine for elderly patients using the IntelliDrug intraoral device: In vivo animal studies. Curr Pharm Des 2010;16:653-9
45. De Caro V, Giandalia G, Siragusa MG, et al. New prospective in treatment of Parkinson's disease: Studies on permeation of ropinirole through buccal mucosa. Int J Pharm 2012;429:78-83
46. Wei R, Simon L, Hu L, et al. Effects of iontophoresis and chemical enhancers on the transport of lidocaine and nicotine across the oral mucosa. Pharm Res 2012;29:961-71
47. Hu L, Silva SM, Damaj BB, et al. Transdermal and transbuccal drug delivery systems: Enhancement using iontophoretic and chemical approaches. Int J Pharm 2011;421:53-62
48. Tanaka H, Fukuda H, Kohno E, et al. Experimental study on iontophoresis for topical application of 5-aminolevulinic acid to the oral mucosa. Int Congr Ser 2003;1248:425-9
49. Paderni C, Campisi G, Schumacher A, et al. Controlled delivery of naltrexone by an intraoral device: In vivo study on human subjects. Int J Pharm 2013;published on line 2 May; DOI:10.1016/j.ijpharm.2013.04.070
50. Mudry B, Carrupt PA, Guy RH, et al. Quantitative structure-permeation relationship for iontophoretic transport across the skin. J Control Release 2007;122:165-72
51. Kalia YN, Naik A, Garrison J, et al. Iontophoretic drug delivery. Adv Drug Deliv Rev 2004;56:619-58
52. Moscicka-Studzinska A, Kijeńska E, Ciach T. Electroosmotic flow as a result of buccal iontophoresis - buccal mucosa properties. Eur J Pharm Biopharm 2009;72:595-59
53. Ciach T, Moscicka-Studzinska A. Buccal iontophoresis: An opportunity for drug delivery and metabolite monitoring. Drug Discov Today 2011;16:361-6
54. Imanidis G, Luetolf P. An extended model based on the modified Nernst-Planck equation for describing transdermal iontophoresis of weak electrolytes. J Pharm Sci 2006;95:1434-47
55. Li D, Hou H. Oral cavity delivery system of unfractionated and low molecular weight heparin. Acta Pharm Sin 2010;45:1317-21
56. Damecha LD, Rajendra VB, Rathi AA, et al. Physical approaches to penetration enhancement. Int J Health Res 2010;3:57-70
57. Denet AR, Vanbever R, Preat V. Electroporation for transdermal and topical delivery. Adv Drug Deliv Rev 2004;56:659-74
58. Escobar-Chávez JJ, Rodríguez-Cruz IM, Domínguez- Delgado CL. Chemical and physical enhancers for transdermal drug delivery. In: Gallelli L, editor. Pharmacology, InTech, 2012.p. 397-434. Available from: Http://www.intechopen.com/books/pharmacology/chemical-and-physicalenhancers-for- transdermal-drug-de livery
59. Talele S. Drug delivery by electroporation: Review. In: Sobh T, Elleithy K, editors. Emerging trends in computing, informatics, systems sciences and engineering. Lecture Notes in Electrical Engineering Volume 151 Springer-Verlag; Berlin: 2013. p. 567-75
60. Shinde UP, Pagar HB, Barhate SD, et al. Recent advances in transdermal drug delivery system. J Pharm Res 2012;5:447-56
61. Vanbever R, Preat V. Factors affecting transdermal delivery of metoprolol by electroporation. Bioelectrochem Bioenerg 1995;38:223-8
62. Ball C, Thomson KR, Kavnoudias H. Irreversible Electroporation: A new challenge in "out of operating theater" anesthesia. Anesth Analg 2010;110:1305-9
63. Mori K, Tokumoto S, Higo N, et al. Transdermal/transmucosal preparations for electroporation. US20050085869A1; 2005
64. Uhland S, Peeters E, Wong S. Transmucosal drug delivery device and methods including elettrically-actuated permeation enhancement. US20110087155A1; 2011
65. Mussivand T, Morshed BI, Shams M. Device for electroporation and lysis. US20120219987A1; 2012
66. Kemmerrer SV, McCoy J, Broderik K. Oral mucosal electroporation device and use thereof. WO2011137221A1; 2011
67. Mitragotri S, Blankschtein D, Langer R. Transdermal drug delivery using low-frequency sonophoresis. Pharm Res 1996;13:411-20
68. Tezel A, Sens A, Tucscherer J, et al. Frequency-dependence of sonophoresis. Pharm Res 2001;18:1694-700
69. Polat BE, Blankschtein D, Langer R. Low-frequency sonophoresis: Application to the transdermal delivery of macromolecules and hydrophilic drugs. Expert Opin Drug Deliv 2010;7:1415-32
70. Escobar Chávez JJ, Martínez DB, González MAV. The use of sonophoresis in the administration of drugs throughout the skin. J Pharm Pharm Sci 2009;12:88-115
71. Pahade A, Jadhav VM, Kadam VJ. Sonophoresis: An overview. Int J Pharm Sci Rev Res 2010;2:24-32
72. Lavon I, Kost J. Ultrasound and transdermal drug delivery. Drug Discov Today 2004;9:670-6
73. Tezel A, Mitragotri S. Interactions of inertial cavitation collapses with stratum corneum lipid bilayers. Biophys J 2003;85:1-11
74. Merino G, Kalia YN, Delgado-Charro MB, et al. Frequency and thermal effects on the enhancement of transdermal transport by sonophoresis. J Control Release 2003;88:85-94
75. Mitragotri S, Edwards DA, Blankschtein D, et al. A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J Pharm Sci 1995;84:697-706
76. Saroha K, Sharma B, Yadav B. Sonophoresis: An advanced tool in transdermal drug delivery system. Int J Curr Pharm Res 2011;3:89-97
77. Kost J, Langer RS. Ultrasound enhancement of buccal drug delivery. US4948587; 1990
78. Rowe S, Kost J, Mitragotri S, et al. Ultrasound enhancement of transdermal transport. US6234990B1; 2001
79. D'Sa JM, Keister JC. Sonophoresis method and apparatus. US6322532B1; 2001
80. D'Sa JM, Keister JC. Sonophoresis apparatus. EP1089788 A1; 2003
81. Nakashima M, Tachibana K. Dental ultrasonic drug delivery system and dental ultrasonic drug delivery method. US20120270177; 2012
82. Benson HAE, McElnay JC, Harland R. Phonophoresis of lignocaine and prilocaine from EMLA cream. Int J Pharm 1988;44:65-9
83. Anon. Update on thermal bioeffects issues. Ultrasound Med Biol 1998;24:S1-S10
84. Anon. Section 8-clinical relevance American Institute of Ultrasound in Medicine References. J Ultrasound Med 2000;19:149-68
85. Biel MA, Janssen W, Trump MF. Photodynamic therapy to the oral cavity, tongue and larynx: A canine normal tissue tolerance study. Lasers Med Sci 1995;10:13-18
86. Jerjes W, Hamdoon Z, Hopper C. Photodynamic therapy in the management of potentially malignant and malignant oral disorders. Head Neck Oncol 2012;4:16
87. Ormond AB, Freeman HS. Dye sentitizers for photodynamic therapy. Materials 2013;6:817-40
88. Meisel P, Kocher T. Photodynamic therapy for periodontal diseases: State of the art. J Photochem Photobiol B 2005;79:159-70
89. Gursoy H, Ozcakir-Tomruk C, Tanalp J, et al. Photodynamic therapy in dentistry: A literature review. Clin Oral Invest 2013;17:1113-25
90. Quon H, Grossman CE, Finlay JC, et al. Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma. Photodiagnosis Photodyn Ther 2011;8:75-85
91. Aghahosseini F, Arbabi-Kalati F, Fashtami LA, et al. Treatment of oral lichen planus with photodynamic therapy mediated methylene blue: A case report. Med Oral Patol Oral Cir Bucal 2006;11:E126-9
92. Cafaro A, Broccoletti R, Arduino PG. Low-level laser therapy for oral mucous membrane pemphigoid. Lasers Med Sci 2012;27:1247-50
93. Canavesi C, Fournier F, Cassarly WJ, et al. Illumination devices for photodynamic therapy of the oral cavity. Biomed Opt Express 2010;1:1480-90
94. Sudhakara RR, Ramya K, Ramesh T, et al. Photodynamic therapy in oral diseases. Int J Biol Med Res 2012;3:1875-83
95. Junqueira JC, Jorge AOC, Barbosa JO, et al. Photodynamic inactivation of biofilms formed by Candida spp., Trichosporon mucoides, and Kodamaea ohmeri by cationic nanoemulsion of zinc 2,9,16,23-tetrakis(phenylthio)-29H,31H- phthalocyanine (ZnPc). Lasers Med Sci 2012;27:1205-12
96. Martins CVB, da Silva DL, Neres ATM, et al. Curcumin as a promising antifungal of clinical interest. J Antimicrob Chemother 2009;63:337-9
97. Yu H, Huang Q. Enhanced in vitro anti-cancer activity of curcumin encapsulated in hydrophobically modified starch. Food Chem 2010;119:669-74
98. Ribeiro APD, Pavarina AC, Dovigo LN, et al. Phototoxic effect of curcumin on methicillin-resistant Staphylococcus aureus and L929 fibroblasts. Lasers Med Sci 2013;28:391-8
99. Dovigo LN, Pavarina AC, Ribeiro APD, et al. Investigation of the photodynamic effects of curcumin against Candida albicans. Photochem Photobiol 2011;87:895-903
100. Ogura M, Abernethy AD, Blissett RD, et al. Photomechanical wave-assisted molecular delivery in oral biofilms. World J Microbiol Biotechnol 2007;23:1637-46
101. Dhamecha DL, Rajendra VB, Rathi AA, et al. Physical approaches to penetration enhancement. Int J Health Res 2010;3:57-70
102. Margetis PM, Quarantillo EP, Lindberg RB. Jet injection local anesthesia in dentistry: A report of 66 cases. U S Armed Forces Med J 1958;9:625-34
103. Arapostathis KN, Dabarakis NN, Coolidge T, et al. Comparison of acceptance, preference, and efficacy between jet injection INJEX and local infiltration anesthesia in 6 to 11 year old dental patients. Anesth Prog 2010;57:3-12
104. Sharma SS, Aruna Sharma S, Saravanan C, et al. Newer local anaesthetic drugs and delivery systems in dentistry - an update. J Dent Med Sci 2012;1:10-16
105. Dabarakis NN, Alexander V, Tsirlis AT, et al. Needle-less local anesthesia: Clinical evaluation of the effectiveness of the jet anesthesia Injex in local anesthesia in dentistry. Quintessence Int 2007;38:E572-6
106. Kwon KC, Verma D, Singh ND, et al. Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv Drug Deliv Rev 2012;In press
107. Mitragotri S. Devices for overcoming biological barriers: The use of physical forces to disrupt the barriers. Adv Drug Deliv Rev 2013;65:100-3
108. Edwards ET, Edwards ES, Licata MJ. Devices, systems and methods for medicament delivery. US8016788B2; 2011
109. Edwards ET, Edwards ES, Licata MJ, et al. Devices, systems and methods for medicament delivery. US8231573B2; 2012
110. Peyman GA. Sub-mucosal agent delivery apparatus, system and method. US12931834; 2011
111. Peyman GA. Sub-mucosal agent delivery apparatus, system and method. US12932941; 2011